Search

Your search keyword '"Linker, Ralf A."' showing total 1,012 results

Search Constraints

Start Over You searched for: Author "Linker, Ralf A." Remove constraint Author: "Linker, Ralf A."
1,012 results on '"Linker, Ralf A."'

Search Results

5. Weaning and extubation failure in myasthenic crisis: a multicenter analysis

6. Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany

9. TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma

10. Sodium perturbs mitochondrial respiration and induces dysfunctional Tregs

11. Seronegative myasthenic crisis: a multicenter analysis

15. Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity

16. Dietary galactose exacerbates autoimmune neuroinflammation via advanced glycation end product-mediated neurodegeneration.

18. Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study

22. Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper)

23. Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis

28. Zoonotic spillover infections with Borna disease virus 1 leading to fatal human encephalitis, 1999–2019: an epidemiological investigation

29. Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism

32. Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis

36. Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland

39. Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting

40. Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study

42. Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation

47. Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective study

48. Real-world data on eculizumab treatment in NMOSD: high efficacy and potential challenges (P13-5.017)

50. Role of the receptor Mas in macrophage-mediated inflammation in vivo

Catalog

Books, media, physical & digital resources